Nova Mentis Life Science Corp (TSE:NOVA) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Nova Mentis Life Science Corp., a Canadian biotech leader in neuroinflammatory diagnostics and therapeutics, has announced the addition of experienced entrepreneur Steve Loutskou to its Board of Directors. Loutskou, known for his strategic vision and financial expertise, has a track record of advancing start-ups and attracting investments. His appointment is expected to bolster Nova’s business strategies and operations.
For further insights into TSE:NOVA stock, check out TipRanks’ Stock Analysis page.
